Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Top 20 Prescription Drugs of 2026
Shots: 20. Vyndaqel Family Non-Proprietary Name: Tafamidis Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.38B 19. Prevnar Family Non-Proprietary Name: Pneumococcal Conjugate Vaccines Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.49B 18. Cosentyx Non-Proprietary Name: Upadacitinib Company: Novartis First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.
Read Full Article
Pharma Tech
ERS 2026: BMI, type-2 inflammation, and asthma attack risk
At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Meta-Analysis (ORACLE2).
Read Full Article
Pharma Tech
Staunch biotech competition spurs new secretive tactics, shifts investor approach
Biotechs and investors are increasingly altering their strategies amid changes in the development and commercial landscape.
Read Full Article
Pharma Tech
Exegenesis Bio and Modalis sign research deal for Duchenne therapy
Exegenesis Bio and Modalis Therapeutics have entered into a research partnership and licence agreement to progress MDL-201, a therapeutic candidate for DMD.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Sep 12, 2026, 2:00 AM
Alembic Pharma's Vadodara bioequivalence facility clears USFDA inspection
In a regulatory filing, the company said the United States Food and Drug Administration (USFDA) carried out the onsite bioequivalence inspection from August 31, 2026, to September 10, 2026.
ET Pharma
Sep 12, 2026, 1:55 AM
GSK to shut vaccine factory in Germany, putting 641 jobs at risk
The closure would put 641 jobs at risk, according to German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).
PharmaShots
Sep 11, 2026, 1:30 PM
Top 20 Prescription Drugs of 2026
Shots: 20. Vyndaqel Family Non-Proprietary Name: Tafamidis Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.38B 19. Prevnar Family Non-Proprietary Name: Pneumococcal Conjugate Vaccines Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.49B 18. Cosentyx Non-Proprietary Name: Upadacitinib Company: Novartis First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.
Pharma Tech
Sep 11, 2026, 1:10 PM
HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.
Pharma Tech
Sep 11, 2026, 1:04 PM
ERS 2026: BMI, type-2 inflammation, and asthma attack risk
At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Meta-Analysis (ORACLE2).
PharmaShots
Sep 11, 2026, 12:30 PM
Lundbeck’s Asedebart Receives the US FDA Orphan Drug Designation for Endogenous Cushing’s Syndrome
Shots: Ref: PRnewswire | Image: Lundbeck | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Lundbeck’s Asedebart Receives the US FDA Orphan Drug Designation for Endogenous Cushing’s Syndrome appeared first on PharmaShots.
News
Latest industry coverage
Google News
Sep 13, 2026, 2:17 AM
Holiferm And Organica UK Combine To Build Integrated Biotech And Sustainable Products Platform - Pulse 2.0
Holiferm And Organica UK Combine To Build Integrated Biotech And Sustainable Products Platform Pulse 2.0
Google News
Sep 12, 2026, 8:33 PM
PHARMACEUTICAL SPEAKERS: THE COMPLETE GUIDE TO FIND, BOOK & HIRE A KEYNOTE FOR CORPORATE EVENTS - futuristsspeakers.com
PHARMACEUTICAL SPEAKERS: THE COMPLETE GUIDE TO FIND, BOOK & HIRE A KEYNOTE FOR CORPORATE EVENTS futuristsspeakers.com
Google News
Sep 12, 2026, 7:36 PM
Can Merck (NYSE:MRK) Outgrow Its Valuation Concerns? - Kalkine Media
Can Merck (NYSE:MRK) Outgrow Its Valuation Concerns? Kalkine Media
Google News
Sep 12, 2026, 7:04 PM
China’s plan to leap ahead in race for next big weight-loss drug - The Australian
China’s plan to leap ahead in race for next big weight-loss drug The Australian
Google News
Sep 12, 2026, 4:00 PM
Sun Pharma Subsidiaries Settle with Plaintiff in US Generic Drug Pricing Litigation - Medical Dialogues
Sun Pharma Subsidiaries Settle with Plaintiff in US Generic Drug Pricing Litigation Medical Dialogues
Google News
Sep 12, 2026, 2:15 PM
Europe risks losing its cell and gene therapy advantage - The Pharma Letter
Europe risks losing its cell and gene therapy advantage The Pharma Letter
Google News
Sep 12, 2026, 1:26 PM
Plastic Multi-Compartment Vial Trays Market Forecast to 2035, Driven by Pharma Automation and 4-6% CAGR - IndexBox
Plastic Multi-Compartment Vial Trays Market Forecast to 2035, Driven by Pharma Automation and 4-6% CAGR IndexBox
Google News
Sep 12, 2026, 12:03 PM
India Joint Venture Partners To Manufacture Pharmaceutical Products In Moscow & Kaluga - russia's pivot to asia
India Joint Venture Partners To Manufacture Pharmaceutical Products In Moscow & Kaluga russia's pivot to asia
Google News
Sep 12, 2026, 11:43 AM
Experts champion quality and safety to drive India’s Biopharma SHAKTI Vision conclave - pharmabiz.com
Experts champion quality and safety to drive India’s Biopharma SHAKTI Vision conclave pharmabiz.com
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer